Full Press Release Details
AMSTERDAM, the Netherlands, May 12, 2016 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced that its management will be presenting at the below listed investor conferences in May and June, 2016.
Piper Jaffray GenomeRx Symposium
Venue: The InterContinental New York Barclay Hotel, New York City
Title: Getting to the Heart (& Muscle) of the Gene Therapy Matter
Presenter: Christian Meyer, Chief Medical Officer
Date and Time: May 17, 2016: 10.40 AM EDT
2016 UBS Global Healthcare Conference
Venue: Grand Hyatt New York Hotel, New York City
Presenter: Daniel Soland, Chief Executive Officer
Date and Time: May 24, 2016: 08.00 AM EDT
Webcast: A webcast of the presentation will be available through the details listed below
Jefferies 2016 Healthcare Conference
Venue: Grand Hyatt New York Hotel, New York City
Presenter: Matt Kapusta, Chief Financial Officer
Date and Time: June 10, 2016: 11.00 AM EDT
The webcast, including a slide presentation at the 2016 UBS Global Healthcare Conference, can be accessed through the following link: https://cc.talkpoint.com/ubsx001/052316a_ae/?entity=47_SI2EH82 or by accessing the link displayed in the "Events" section on the "Media" page of the uniQure website at: http://www.uniqure.com/news/calendar-of-events/. The replay of the webcast will be available one hour after the conclusion of the live event and archived on the uniQure website for at least 30 days following the webcast.
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with CNS, liver/metabolic and cardiovascular diseases. www.uniQure.com